Low awareness that fatty liver can silently progress and that MASH fibrosis is treatable drives missed follow-up testing, says Rohit Loomba, MD.
Rohit Loomba, MD, MHSc
Advertisement
Rohit Loomba, MD, MHSc, is director of the MASLD Research Center and chief of the Division of Gastroenterology and Hepatology at the University of California, San Diego.
Articles by Rohit Loomba, MD, MHSc
Advertisement
Latest Updated Articles
Advertisement
Advertisement
Trending on AJMC
1
FDA Approves Asundexian, First FXIa Inhibitor to Prevent Repeat Stroke
2
How Plans, Clinicians Should Handle Gray-Market Retatrutide
3
IVF Beats IUI for Early Live Births in Unexplained Infertility
4
Phase 3 Data Back ALP Normalization as Treatment Goal in PBC
5